EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comparative interactome mapping of Tau‐protein in classical and rapidly progressive Alzheimer's disease identifies subtype‐specific pathways

Abrar Younas, Neelam Younas iD, Muhammad Javed Iqbal, Isidre Ferrer iD, Inga Zerr

Neuropathology and Applied Neurobiology · 2024-02 · 50 (1)

DOI: 10.1111/nan.12964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, online erschienen am 19.02.2024. Verfasst von Abrar Younas und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Center for Surveillance of TSE, Department of Neurology, University Medical Center Göttingen, Göttingen, Germany. Hauptthemen laut MEDLINE: Alzheimer Disease, Tauopathies. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Tau is a key player in Alzheimer's disease (AD) and other Tauopathies. Tau pathology in the brain directly correlates with neurodegeneration in AD. The recent identification of a rapid variant of AD demands an urgent need to uncover underlying mechanisms leading to differential progression in AD. Accordingly, we aimed to dissect the underlying differential mechanisms of toxicity associated with the Tau protein in AD subtypes and to find out subtype‐dependent biomarkers and therapeutic targets.

Methods

To identify and characterise subtype‐specific Tau‐associated mechanisms of pathology, we performed comparative interactome mapping of Tau protein in classical AD (cAD) and rapidly progressive AD (rpAD) cases using co‐immunoprecipitation coupled with quantitative mass spectrometry. The mass spectrometry data were extensively analysed using several bioinformatics approaches.

Results

The comparative interactome mapping of Tau protein revealed distinct and unique interactors (DPYSL4, ARHGEF2, TUBA4A and UQCRC2) in subtypes of AD. Interestingly, an analysis of the Tau‐interacting proteins indicated enrichment of mitochondrial organisation processes, including negative regulation of mitochondrion organisation, mitochondrial outer membrane permeabilisation involved in programmed cell death, regulation of autophagy of mitochondrion and necroptotic processes, specifically in the rpAD interactome. While, in cAD, the top enriched processes were related to oxidation–reduction process, transport and monocarboxylic acid metabolism.

Conclusions

Overall, our results provide a comprehensive map of Tau‐interacting protein networks in a subtype‐dependent manner and shed light on differential functions/pathways in AD subtypes. This comprehensive map of the Tau‐interactome has provided subsets of disease‐related proteins that can serve as novel biomarkers/biomarker panels and new drug targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseTauopathiesHumanstau ProteinsBrainBiomarkersRho Guanine Nucleotide Exchange Factors

Stichwörter der Autor:innen

Taubiomarkersdrug targetsinteractomemass spectrometryrapidly progressive Alzheimer's disease

Substanzen

tau ProteinsBiomarkersARHGEF2 protein, humanRho Guanine Nucleotide Exchange Factors

Autor:innen und Institutionen

  • National Reference Center for Surveillance of TSE, Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
  • German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
  • Department of Biological Sciences, Faculty of Sciences, University of Sialkot, Sialkot, Pakistan.
  • Department of Biotechnology, Faculty of Sciences, University of Sialkot, Sialkot, Pakistan.
  • Department of Pathology and Experimental Therapeutics, University of Barcelona, Hospitalet de Llobregat, Spain.

ORCID-Profile: Neelam Younas, Isidre Ferrer

Zitieren

APA

Younas, A., Younas, N., Iqbal, M. J., Ferrer, I., & Zerr, I. (2024). Comparative interactome mapping of Tau‐protein in classical and rapidly progressive Alzheimer's disease identifies subtype‐specific pathways. Neuropathology and Applied Neurobiology, 50(1). https://doi.org/10.1111/nan.12964

Vancouver

Younas A, Younas N, Iqbal MJ, Ferrer I, Zerr I. Comparative interactome mapping of Tau‐protein in classical and rapidly progressive Alzheimer's disease identifies subtype‐specific pathways. Neuropathology and Applied Neurobiology. 2024;50(1). doi:10.1111/nan.12964

BibTeX
@article{Younas2024,
  author = {Younas, Abrar and Younas, Neelam and Iqbal, Muhammad Javed and Ferrer, Isidre and Zerr, Inga},
  title = {Comparative interactome mapping of Tau‐protein in classical and rapidly progressive Alzheimer's disease identifies subtype‐specific pathways},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2024},
  volume = {50},
  number = {1},
  doi = {10.1111/nan.12964}
}
Kostenlos starten →